How big is the North America Insulin Delivery Devices Market?

The North America Insulin Delivery Devices Market size is expected to reach USD 14.59 million in 2024 and grow at a CAGR of 5.06% to reach USD 18.91 million by 2029. Read More

What is the current North America Insulin Delivery Devices Market size?

In 2024, the North America Insulin Delivery Devices Market size is expected to reach USD 14.59 million. Read More

Who are the key players in North America Insulin Delivery Devices Market?

Novo Nordisk, Medtronic, Sanofi, Eli Lilly and Company and Becton and Dickinson are the major companies operating in the North America Insulin Delivery Devices Market. Read More

What years does this North America Insulin Delivery Devices Market cover, and what was the market size in 2023?

In 2023, the North America Insulin Delivery Devices Market size was estimated at USD 13.85 million. The report covers the North America Insulin Delivery Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Insulin Delivery Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

North America Insulin Delivery Devices Market Share

Statistics for the 2023 & 2024 North America Insulin Delivery Devices market share, created by Mordor Intelligence™ Industry Reports. North America Insulin Delivery Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of North America Insulin Delivery Devices Industry

The North American insulin delivery devices market is moderately consolidated due to the presence of major players such as Novo Nordisk, Sanofi, Eli Lilly and Company, Medtronic, Insulet, Ypsomped, Becton Dickinson and Company, etc. operating globally and other regional players.